Early Examples of Diagnostic Intellectual Property

Strong pipeline of Intellectual Property opportunities in the diagnostic field, across all the TMRC therapeutic areas - these include:

• Transgenic model for schizophrenia.
• Analysis software for predicting fracture risk and disease progression in osteoarthritis.
• Novel antibody-based and qPCR assays of inflammation parameters in asthma.
• Multiplex genotyping assay for population screening for risk factors associated with cardiovascular disease, diabetes, obesity and metabolic syndrome.
• Multiplex genetic test for prediction of treatment response and disease progression in colorectal cancer.
• MS assay and methodology for quantitative measurement of phosphorylation status of a key signalling pathway in human cancers and tumourogenesis.
• Biomarkers of response to neoadjuvant chemotherapy.
• Novel biomarkers of endometrial dysfunction